BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37221563)

  • 1. Microglia degrade Tau oligomers deposit via purinergic P2Y12-associated podosome and filopodia formation and induce chemotaxis.
    Chinnathambi S; Das R
    Cell Biosci; 2023 May; 13(1):95. PubMed ID: 37221563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau aggregates improve the Purinergic receptor P2Y12-associated podosome rearrangements in microglial cells.
    Chinnathambi S; Das R; Desale SE
    Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119477. PubMed ID: 37061007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial remodeling of actin network by Tau oligomers, via G protein-coupled purinergic receptor, P2Y12R-driven chemotaxis.
    Das R; Chinnathambi S
    Traffic; 2021 May; 22(5):153-170. PubMed ID: 33527700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-protein coupled purinergic P2Y12 receptor interacts and internalizes Tau
    Chidambaram H; Das R; Chinnathambi S
    Eur J Cell Biol; 2022 Apr; 101(2):151201. PubMed ID: 35101770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer's Disease.
    Das R; Chinnathambi S
    Neuroscience; 2020 Nov; 448():325-336. PubMed ID: 32941933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia.
    Das R; Balmik AA; Chinnathambi S
    J Neuroinflammation; 2020 Jan; 17(1):10. PubMed ID: 31915009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic Receptor P2Y12-Mediated Tau Internalization in Microglia.
    Chidambaram H; Desale SE; Chinnathambi S
    Methods Mol Biol; 2024; 2754():457-470. PubMed ID: 38512682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of podosome formation, microglial migration and invasion by Ca(2+)-signaling molecules expressed in podosomes.
    Siddiqui TA; Lively S; Vincent C; Schlichter LC
    J Neuroinflammation; 2012 Nov; 9():250. PubMed ID: 23158496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein coupled receptors regulates Tauopathy in neurodegeneration.
    Chinnathambi S; Chidambaram H
    Adv Protein Chem Struct Biol; 2024; 141():467-493. PubMed ID: 38960483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Tau with G-Protein-Coupled Purinergic P2Y12 Receptor by Molecular Docking and Molecular Dynamic Simulation.
    Chidambaram H; Desale SE; Chinnathambi S
    Methods Mol Biol; 2024; 2754():33-54. PubMed ID: 38512659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Linolenic acid induces clearance of Tau seeds via Actin-remodeling in Microglia.
    Desale SE; Chinnathambi S
    Mol Biomed; 2021 Feb; 2(1):4. PubMed ID: 35006402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor.
    Maeda J; Minamihisamatsu T; Shimojo M; Zhou X; Ono M; Matsuba Y; Ji B; Ishii H; Ogawa M; Akatsu H; Kaneda D; Hashizume Y; Robinson JL; Lee VM; Saito T; Saido TC; Trojanowski JQ; Zhang MR; Suhara T; Higuchi M; Sahara N
    Brain Commun; 2021; 3(1):fcab011. PubMed ID: 33644757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial purinergic signaling in Alzheimer's disease.
    Mei SY; Zhang N; Wang MJ; Lv PR; Liu Q
    Purinergic Signal; 2024 Jun; ():. PubMed ID: 38910192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial P2Y12 deficiency/inhibition protects against brain ischemia.
    Webster CM; Hokari M; McManus A; Tang XN; Ma H; Kacimi R; Yenari MA
    PLoS One; 2013; 8(8):e70927. PubMed ID: 23940669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease.
    Wang Z; Weaver DF
    Int Immunopharmacol; 2022 Sep; 110():109070. PubMed ID: 35978514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct P2Y Receptors Mediate Extension and Retraction of Microglial Processes in Epileptic and Peritumoral Human Tissue.
    Milior G; Morin-Brureau M; Chali F; Le Duigou C; Savary E; Huberfeld G; Rouach N; Pallud J; Capelle L; Navarro V; Mathon B; Clemenceau S; Miles R
    J Neurosci; 2020 Feb; 40(7):1373-1388. PubMed ID: 31896671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of beta1 integrin in microglial chemotaxis and proliferation on fibronectin: different regulations by ADP through PKA.
    Nasu-Tada K; Koizumi S; Inoue K
    Glia; 2005 Nov; 52(2):98-107. PubMed ID: 15920726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crosstalk between extracellular matrix proteins and Tau.
    Chinnathambi S; Desale SE
    Adv Protein Chem Struct Biol; 2024; 141():447-466. PubMed ID: 38960482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia display modest phagocytic capacity for extracellular tau oligomers.
    Majerova P; Zilkova M; Kazmerova Z; Kovac A; Paholikova K; Kovacech B; Zilka N; Novak M
    J Neuroinflammation; 2014 Sep; 11():161. PubMed ID: 25217135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.